{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:03:30Z","timestamp":1754107410867,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jocn.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T07:58:24Z","timestamp":1542873504000},"page":"276-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Peroxisome proliferator-activated receptor-\u03b3 activation attenuates harmaline-induced cognitive impairments in rats"],"prefix":"10.1016","volume":"59","author":[{"given":"Iraj","family":"Aghaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Hajali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Haghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5707-0507","authenticated-orcid":false,"given":"Zohreh","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-514X","authenticated-orcid":false,"given":"Mahmmod","family":"Moosazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.11.004_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrneurol.2009.196","article-title":"The clinical approach to movement disorders","volume":"6","author":"Abdo","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2018.11.004_b0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson\u2019s disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2018.11.004_b0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jnnp.2010.229740","article-title":"Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases","volume":"82","author":"Louis","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2018.11.004_b0020","doi-asserted-by":"crossref","unstructured":"Benito-Le\u00f3n J, Louis ED. Essential Tremor. Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment; 2012:73.","DOI":"10.1002\/9781444346183.ch6"},{"key":"10.1016\/j.jocn.2018.11.004_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/brain\/89.1.37","article-title":"Striatal amines, experimental tremor and the effect of harmaline in the monkey","volume":"89","author":"Poirier","year":"1966","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2018.11.004_b0030","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1021\/jm1000024","article-title":"Bivalent \u03b2-carbolines as potential multitarget anti-Alzheimer agents","volume":"53","author":"Rook","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.jocn.2018.11.004_b0035","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1212\/01.WNL.0000038385.60538.19","article-title":"Elevation of blood \u03b2-carboline alkaloids in essential tremor","volume":"59","author":"Louis","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.11.004_b0040","unstructured":"Cheng MM-H, Tang G, Kuo S-H. Harmaline-induced tremor in mice: videotape documentation and open questions about the model. Tremor and Other Hyperkinetic Movements. 2013. [doi: 10.7916\/D8H993W3]."},{"key":"10.1016\/j.jocn.2018.11.004_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3940(99)00026-9","article-title":"Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3, 4-dihydroxyphenylacetic acid","volume":"261","author":"Desvignes","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2018.11.004_b0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2010.09.010","article-title":"Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro","volume":"649","author":"Hamsa","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jocn.2018.11.004_b0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.bjp.0706024","article-title":"Modulation of voltage-gated channel currents by harmaline and harmane","volume":"144","author":"Splettstoesser","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jocn.2018.11.004_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(97)00606-9","article-title":"Harmaline competitively inhibits [3H] MK-801 binding to the NMDA receptor in rabbit brain","volume":"770","author":"Du","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2004.03.021","article-title":"Vagus nerve stimulation inhibits harmaline-induced tremor","volume":"1011","author":"Krahl","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/15209150050194297","article-title":"Thiazolidinediones: a comparative review of approved uses","volume":"2","author":"Sood","year":"2000","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jocn.2018.11.004_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.jocn.2018.11.004_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainresbull.2015.12.002","article-title":"Alterations in the intrinsic electrophysiological properties of Purkinje neurons in a rat model of hepatic encephalopathy: Relative preventing effect of PPAR\u03b3 agonist","volume":"121","author":"Aghaei","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jocn.2018.11.004_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pbb.2014.03.002","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis","volume":"120","author":"Aghaei","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jocn.2018.11.004_b0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","article-title":"Peroxisome-proliferator-activated receptor-gamma (PPAR\u03b3) activation protects neurons from NMDA excitotoxicity","volume":"1073","author":"Zhao","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0095","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1471-4159.2009.06107.x","article-title":"Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-\u03b3 agonists in cultured hippocampal neurons","volume":"109","author":"Pancani","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2018.11.004_b0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2008001200001","article-title":"Stress-induced neuroinflammation: mechanisms and new pharmacological targets","volume":"41","author":"Munhoz","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-012-2722-0","article-title":"NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice","volume":"223","author":"Salehi-Sadaghiani","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jocn.2018.11.004_b0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.physbeh.2016.06.013","article-title":"Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor","volume":"164","author":"Abbassian","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jocn.2018.11.004_b0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2015.01.078","article-title":"The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor","volume":"590","author":"Vaziri","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2018.11.004_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11011-014-9600-x","article-title":"Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis","volume":"30","author":"Aghaei","year":"2015","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jocn.2018.11.004_b0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.physbeh.2015.02.016","article-title":"Psychological or physical prenatal stress differentially affects cognition behaviors","volume":"142","author":"Nazeri","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jocn.2018.11.004_b0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2011.12.008","article-title":"Female rats are more susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance","volume":"228","author":"Hajali","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0135","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1111\/bph.13581","article-title":"Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat","volume":"173","author":"Abbassian","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jocn.2018.11.004_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-2952(91)90305-O","article-title":"Antioxidative properties of harmane and beta-carboline alkaloids","volume":"42","author":"Tse","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jocn.2018.11.004_b0145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1176\/ajp.113.10.887","article-title":"Psychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline","volume":"113","author":"Pennes","year":"1957","journal-title":"Am J Psychiatry"},{"year":"2012","series-title":"Mechanisms and emerging therapies in tremor disorders","author":"Grimaldi","key":"10.1016\/j.jocn.2018.11.004_b0150"},{"key":"10.1016\/j.jocn.2018.11.004_b0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbr.2012.03.006","article-title":"Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice","volume":"231","author":"Almasi-Nasrabadi","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jocn.2018.11.004_b0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1532-5415.2009.02067.x","article-title":"Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus","volume":"57","author":"Hanyu","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocn.2018.11.004_b0165","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1113\/jphysiol.2009.182196","article-title":"Reduced expression of the Ca2+ transporter protein PMCA2 slows Ca2+ dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination","volume":"588","author":"Empson","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.jocn.2018.11.004_b0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.psyneuen.2008.08.018","article-title":"HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients","volume":"34","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jocn.2018.11.004_b0175","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.lfs.2006.07.004","article-title":"Effects of \u03b2-carboline alkaloids on the object recognition task in mice","volume":"79","author":"Moura","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2018.11.004_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2014.11.012","article-title":"The effect of CA1 dopaminergic system in harmaline-induced amnesia","volume":"285","author":"Nasehi","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jocn.2018.11.004_b0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(99)01230-5","article-title":"Influence of stimulation of the olivocerebellar pathway by harmaline on spatial learning in the rat","volume":"824","author":"Meignin","year":"1999","journal-title":"Brain Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681831066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681831066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T17:12:43Z","timestamp":1572973963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758681831066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"alternative-id":["S096758681831066X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.11.004","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptor-\u03b3 activation attenuates harmaline-induced cognitive impairments in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}